ADTX
ADTX
NASDAQ · Biotechnology

Aditxt Inc

$0.01
+0.00 (+0.00%)
As of Sep 21, 6:25 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 6 75%
Hold 2 25%
Sell 0 0%
Price Target
Analyst Price Target +134,900.0% upside
Low Target $9.80
Average Target $13.50
High Target $19.20
Current Price $0.01
Current
$0.01
Target
$13.50
$9.80 $13.50 avg $19.20
Scenario Analysis
Bear Case
$9.80
97,900.0%
Low target
Base Case
$13.50
+134,900.0%
Avg target
Bull Case
$19.20
+191,900.0%
High target
Risk/Reward
2.0x
Balanced
Price in Context
Target vs 52W High
$13.50
-99.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.6%
AMGN
Amgen Inc
Hold 43 47% $190.87 -51.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +140.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.2%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%